Imagine a future where the global incident cases of liver cancer almost doubles, rising from 870 000 cases in 2022 to over 1·5 million in 2050. This scenario, and all the attendant harms to health and...

Lancet Commission says three in five cases preventable with action on obesity, alcohol and hepatitis

The expansion of clones with distinct SERPINA1 somatic mutants in the livers of alpha-1 antitrypsin deficiency (A1AT) patients is consistent with convergent evolution. These variants interfere with th...

Nature Genetics - The expansion of clones with distinct SERPINA1 somatic mutants in the livers of alpha-1 antitrypsin deficiency (A1AT) patients is consistent with convergent evolution. These...

The expansion of clones with distinct SERPINA1 somatic mutants in the livers of alpha-1 antitrypsin deficiency (A1AT) patients is consistent with convergent evolution. These variants interfere with th...

Research Assistant (Computational biology) (Fixed Term) in the Department of Oncology at the University of Cambridge.

Research Assistant (Computational biology) (Fixed Term) in the Department of Oncology at the University of Cambridge.

Nature - As proof of principle, an analysis using a suite of human-aligned immunocompetent mouse models of hepatocellular carcinoma identifies a promising therapeutic candidate, cladribine, which...

Post-doctoral Research Associate (Fixed Term) in the Department of Medicine at the University of Cambridge.

The good, the bad, and the ugly: tissue somatic evolution in ageing and disease

This decision analytical modeling study estimates the burden of metabolic dysfunction–associated steatotic liver disease among US adults from 2020 to 2050.

ALT: someone is holding a fortune cookie that says " i love it when a plan comes together "

Associate Professor/Professor of Infection and/or Immunity in the Department of Pathology at the University of Cambridge.